Atropine Sulfate Injection, Solution
Product Images NDC 64253-400

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 64253-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medefil, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Atropine)

FDA Label Image

Syringe Label (L4338 R001 Syringe Label)

FDA Label Image

Package Insert Page 1 (L4353 R000 Pkg Insert Page 1)

Package Insert Page 1 (L4353 R000 Pkg Insert Page 1)
Atropine Sulfate Injection is a medication used for temporary blockade of severe or life-threatening muscarinic effects caused by organophosphorus or muscarinic mushroom poisoning, bradyasystolic cardiac arrest, and as an antisialagogue or antivagal agent. It is administered through intravenous route, and titrated based on heart rate, blood pressure, PR interval, and symptoms. It is contraindicated for no one, but caution should be exercised when used in patients with coronary artery disease, acute glaucoma, pyloric obstruction, complete urinary retention, and patients with chronic lung diseases. Adverse reactions commonly associated with atropine use are dryness of the mouth, blurred vision, photophobia, and tachycardia. Pediatric dosing has not been well studied.*
FDA Label Image

Package Insert Page 2 (L4353 R000 Pkg Insert Page 2)

Package Insert Page 2 (L4353 R000 Pkg Insert Page 2)
This is a drug label for Atropine Sulfate Injection, USP. It includes information on drug interactions, use in specific populations such as pregnancy and nursing mothers, pediatric use, geriatric use, overdose symptoms, description, clinical pharmacology, pharmacodynamics, pharmacokinetics, nonclinical toxicology, and how it is supplied, stored, and handled. The drug is supplied in a single-dose syringe and should be stored between 15-30°C (59-86°F).*
FDA Label Image

Master Carton Label (L4354 R000 Master Carton Label)

Master Carton Label (L4354 R000 Master Carton Label)
This is a description of a medication that is for intravenous use only. It comes in a single-dose syringe that should be discarded if there is any unused portion. The usual dosage should be seen in the prescribing information. It needs to be stored between 20°C to 25°C (68°F to 77°F) and may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The medication and fluid path are sterile and nonpyrogenic if the protective cover is undisturbed and the package is intact. It is manufactured by Medefil, Inc., based in Glendale Heights, IL 60139.*
FDA Label Image

Pouch Label (P3028 R000 Pouch Label)

Pouch Label (P3028 R000 Pouch Label)
Not available. The text contains a few letters and random characters that do not form a complete description or make sense.*
FDA Label Image

Dispenser Box 10 Count (10 mL)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.